Detailed information from longitudinal studies about the course and functional outcome of early RA is sparse (1,2). it would be optimal to study a cohort of patients with very early RA but this is seldom done because very few rheumatologists see enough patients with early RA to be able to perform a methodologically sound study. Eberhardt and Fex in a prospective study recently reported the functional outcome of 67 early RA patients followed for 5 years (3). To develop strategies to solve such methodological problems, Dr. Paulus and colleagues formed a Consortium of Practicing rheumatologists (CPR) in 1992 of over 50 physician practices to enroll and additive cohort of patients with very early RA and collect detailed information on the early course and outcome of RA in a 5 to 10 year long term observational study. The goals of this CPR based """"""""Long-term Observation of Severe Early Rheumatoid Arthritis"""""""" study are to identify pre-erosive features that predict the development of joint erosions within 2 years of disease onset, determine whether the development of joint erosions correlate with subsequent disability, costs for medical care and dependence on others, and to observe whether various therapies prevent or delay the onset of joint erosions. Disease status will be assessed in the CPR study at entry, 6 months, and yearly thereafter by traditional assessments, health services methodologies, and joint radiographs. Specifically, tender and swollen joint counts, Westergren ESR (WSR), pain assessment, global assessments, and functional (physical, mental and social) status will be among the disease activity measures that will be evaluated in the CPR study. In addition, patient plasma and serum specimens will be drawn and maintained in a freezer bank for future use testing. Information will be obtained directly from the patients using ARAMIS-based background information forms and the Health Assessment questionnaire (HAQ). The initial set of forms will be given to the patient by the physician, to be mailed back directly to the Coordinating Center at UCLA when completed. Subsequent patient-based data forms for patient completion will be sent directly to the patients from the Coordinating Center.

Project Start
Project End
Budget Start
Budget End
Support Year
9
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Jawaheer, Damini; Maranian, Paul; Park, Grace et al. (2010) Disease progression and treatment responses in a prospective DMARD-naive seropositive early rheumatoid arthritis cohort: does gender matter? J Rheumatol 37:2475-85
Ranganath, Veena K; Yoon, Jeonglim; Khanna, Dinesh et al. (2007) Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohort. Ann Rheum Dis 66:1633-40
Kahn, Katherine L; MacLean, Catherine H; Liu, Honghu et al. (2007) The complexity of care for patients with rheumatoid arthritis: metrics for better understanding chronic disease care. Med Care 45:55-65
Kahn, K L; Maclean, C H; Wong, A L et al. (2007) Assessment of American College of Rheumatology quality criteria for rheumatoid arthritis in a pre-quality criteria patient cohort. Arthritis Rheum 57:707-15
Kahn, K L; MacLean, C H; Liu, H et al. (2006) Application of explicit process of care measurement to rheumatoid arthritis: Moving from evidence to practice. Arthritis Rheum 55:884-91
Liu, Honghu; Harker, Judith O; Wong, Andrew L et al. (2004) Case finding for population-based studies of rheumatoid arthritis: comparison of patient self-reported ACR criteria-based algorithms to physician-implicit review for diagnosis of rheumatoid arthritis. Semin Arthritis Rheum 33:302-10
Riemekasten, Gabriela; Langnickel, Dirk; Enghard, Philipp et al. (2004) Intravenous injection of a D1 protein of the Smith proteins postpones murine lupus and induces type 1 regulatory T cells. J Immunol 173:5835-42
La Cava, Antonio; Ebling, Fanny M; Hahn, Bevra H (2004) Ig-reactive CD4+CD25+ T cells from tolerized (New Zealand Black x New Zealand White)F1 mice suppress in vitro production of antibodies to DNA. J Immunol 173:3542-8
Amjadi-Begvand, Sogol; Khanna, Dinesh; Park, Grace S et al. (2004) Dating the ""window of therapeutic opportunity"" in early rheumatoid arthritis: accuracy of patient recall of arthritis symptom onset. J Rheumatol 31:1686-92
Wong, Andrew L; Harker, Judith O; Mittman, Brian S et al. (2004) Development and evaluation of a patient self-report case-finding method for rheumatoid arthritis. Semin Arthritis Rheum 34:484-99

Showing the most recent 10 out of 111 publications